- Home
- ZNTL vs SEER Comparison
ZNTL vs SEER Comparison
Compare ZNTL & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- SEER
- Stock Information
- Founded
- ZNTL 2014
- SEER 2017
- Country
- ZNTL United States
- SEER United States
- Employees
- ZNTL N/A
- SEER N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- SEER Medicinal Chemicals and Botanical Products
- Sector
- ZNTL Health Care
- SEER Health Care
- Exchange
- ZNTL Nasdaq
- SEER Nasdaq
- Market Cap
- ZNTL 105.8M
- SEER 125.3M
- IPO Year
- ZNTL 2020
- SEER 2020
- Fundamental
- Price
- ZNTL $1.24
- SEER $2.21
- Analyst Decision
- ZNTL Buy
- SEER Hold
- Analyst Count
- ZNTL 7
- SEER 1
- Target Price
- ZNTL $8.60
- SEER $3.00
- AVG Volume (30 Days)
- ZNTL 1.4M
- SEER 207.2K
- Earning Date
- ZNTL 08-08-2025
- SEER 08-07-2025
- Dividend Yield
- ZNTL N/A
- SEER N/A
- EPS Growth
- ZNTL N/A
- SEER N/A
- EPS
- ZNTL N/A
- SEER N/A
- Revenue
- ZNTL $26,865,000.00
- SEER $15,309,000.00
- Revenue This Year
- ZNTL N/A
- SEER $26.18
- Revenue Next Year
- ZNTL N/A
- SEER $29.58
- P/E Ratio
- ZNTL N/A
- SEER N/A
- Revenue Growth
- ZNTL N/A
- SEER N/A
- 52 Week Low
- ZNTL $1.01
- SEER $1.56
- 52 Week High
- ZNTL $5.44
- SEER $2.63
- Technical
- Relative Strength Index (RSI)
- ZNTL 39.75
- SEER 55.05
- Support Level
- ZNTL $1.31
- SEER $1.94
- Resistance Level
- ZNTL $1.39
- SEER $2.18
- Average True Range (ATR)
- ZNTL 0.11
- SEER 0.07
- MACD
- ZNTL -0.03
- SEER 0.00
- Stochastic Oscillator
- ZNTL 8.91
- SEER 52.94
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.